Standardized Benefit Plans: A Tool for Consumers?
National Academy for State Health Policy Thursday, February 18, 2015 2:30 – 4:00 PM ET
Call-in # 1-877-717-9270 Presented with support from PhRMA
Standardized Benefit Plans: A Tool for Consumers? National Academy - - PowerPoint PPT Presentation
Standardized Benefit Plans: A Tool for Consumers? National Academy for State Health Policy Thursday, February 18, 2015 2:30 4:00 PM ET Call-in # 1-877-717-9270 Presented with support from PhRMA Webinar Agenda 2:30 p.m. Introduction
Call-in # 1-877-717-9270 Presented with support from PhRMA
2:30 p.m. Introduction Kevin Lucia, Georgetown University Health Policy Institute 2:35-2:45 p.m. Overview of Proposed Rule on Standardized Plans Sarabeth Zemel, NASHP 2:45–3:30 p.m. Conversation on Standardized Plans Moderator:
Panelists:
Connector
Health Plans 3:30–4:00 p.m. Question and Answer All Panelists and JoAnn Volk, Georgetown University Health Policy Institute *Use the chat feature to submit your questions 4:00 p.m. Wrap-up
Moderator: Kevin Lucia Research Professor Georgetown University Health Policy Institute Heather Cloran Associate Director of Programs & Product Strategy Massachusetts Health Connector
President & CEO RxEconomics Former title, Department Current title, association Wardell Sanders Former Executive Director, New Jersey Individual Health Coverage Program Board and New Jersey Small Employer Health Benefits Program Board Current President, New Jersey Association of Health Plans
22
! More generous coverage may induce moral hazard and overuse of services ! Less generous coverage decreases risk protection and may prompt underuse
$200 individual deductible; 25% coinsurance; $1500 stop-loss (in 1983$)
as advances in prevention and treatment since the 1970s
! How members respond to cost-sharing (i.e., elasticity of demand) ! Economic costs and benefits of specific health services
References Manning, W.G., J.P. Newhouse, N. Duan, E.B. Keeler, A. Leibowitz, and M.S. Marquis. 1987. “Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment.” American Economic Review 77(3): 251-277. Newhouse, J.P. and the Insurance Experiment Group. 1993. “Free for All? Lessons from the RAND Health Insurance Experiment.” Cambridge, MA: Harvard University Press.
23
intended to promote more efficient use of health services
large employer that replaced all of its plans with a CDHP
! Lower total healthcare costs (-25% after 1 year; -6% after 4 years) ! Persistent decreases in the number of physician visits ! Fewer prescriptions filled, which was linked to worsening medication adherence for hypertension, dyslipidemia, diabetes, and depression ! A slight (but significant) increase in emergency department visits ! Marked reductions in quality measures, such as lower likelihoods of receiving breast, cervical, and colorectal cancer screenings
References Fronstin, P., M-J. Sepulveda, and M.C. Roebuck. 2013. “Consumer-Directed Health Plans Reduce the Long-Term Use
Fronstin, P., M-J. Sepulveda, and M.C. Roebuck. 2013. “Medication Utilization and Adherence in a Health Savings Account-Eligible Plan.” American Journal of Managed Care 19(12): e400-e407. And other publications available at www.EBRI.org.
24
inpatient and outpatient services
chronic disease, and medical cost offsets from prescription drug utilization ! In 2012, the Congressional Budget Office changed its methodology for estimating the impact of legislation affecting prescription drug utilization among Medicare beneficiaries. CBO now assumes that a 1.0% increase in the number of prescriptions filled will cause a 0.2% decrease in spending on other medical services
encourage optimal use of high-value services by reducing or eliminating copays, but the math may not always work out
References Roebuck, M.C. Dissertation. “Price Elasticity of Demand for Prescription Drugs: Therapeutic Class-Specific Estimates and Implications for Value-Based Insurance Design.” RxEconomics LLC. Congressional Budget Office. “Offsetting Effects of Prescription Drug Use on Medicare’s Spending for Medical Services.” Washington, DC: CBO; 2012 [cited 2013 March 23]. Available from: http://www.cbo.gov/sites/default/files/cbofiles/attachments/43741-MedicalOffsets-11-29-12.pdf.
25
for all hypertension patients because 50% of its patients are non-adherent
! $0.65 per day; $240 for fully adherent; $120 for partially adherent; averaged
demand be for plan to break even?
! -0.071 intensive margin
close call highly dependent on the equation inputs
References Roebuck, M.C. Dissertation. “Price Elasticity of Demand for Prescription Drugs: Therapeutic Class-Specific Estimates and Implications for Value-Based Insurance Design.” RxEconomics LLC. Roebuck, M.C., J.N. Liberman, M. Gemmill-Toyama, and T.A. Brennan. 2011. “Medication Adherence Leads to Lower Health Care Use and Costs Despite Increased Drug Spending.” Health Affairs 30(1):91-99.
26